Eikon Therapeutics (EIKN)

• Market cap: $527M
• 1 day: 4.74%
• 5 days: 4.74%
• 1 month: -8.03%
• 3 months: -2.21%
• 6 months: -28.4%
• Year to date: -35.13%
• 1 year: -35.13%
• 5 years: -35.13%
• 10 years: -35.13%
• Sector: Healthcare
• Industry: Biotechnology

About: Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Employees: 384